Frank Stephen Hodi, Jr, MD
Harvard Medical School, Dana-Farber Cancer Institute, Melanoma Disease Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA
F. Stephen Hodi, MD, is the Director of the Melanoma Center at Dana-Farber/Brigham and Women’s Cancer Center, the Director of the Center for Immuno-Oncology at Dana-Farber/Brigham and Women’s Cancer Center, the Sharon Crowley Martin Chair in Melanoma at Dana-Farber Cancer Institute, as well as an Associate Professor of Medicine at Harvard Medical School.
Currently, Dr. Hodi’s research is centered on immune therapy for the treatment of malignant melanoma. Dr. Hodi is a member of the National Comprehensive Cancer Network, American Society of Clinical Oncology, Eastern Cooperative Oncology Group Melanoma Committee, and the Society for Immunotherapy of Cancer, as well as a founding member of the Society for Melanoma Research.
Dr. Hodi is a graduate of Harvard College and Cornell University Medical College. He completed his internal medicine training at the University of Pennsylvania and a fellowship in medical oncology at Dana-Farber. Dr. Hodi joined the faculty at Dana-Farber in 1998. His publications include articles in the Proceedings of the National Academy of Sciences, USA Journal of Clinical Oncology and the New England Journal of Medicine.